Ethical issues with newborn screening in the genomics era
- PMID: 22559326
- PMCID: PMC3625041
- DOI: 10.1146/annurev-genom-090711-163741
Ethical issues with newborn screening in the genomics era
Abstract
Continued technological advances have made the prospect of routine whole-genome sequencing (WGS) imminent. To date, much of the discussion about WGS has focused on its application and use in clinical medicine. Relatively little attention has been paid to the potential integration of WGS into newborn screening programs. Given the structure and scope of these programs, it is possible that the early applications of WGS will occur in state-run newborn screening programs. Assessment of the pressing ethical issues currently facing the newborn screening community will provide insight into the challenges that lie ahead in the genomics era.
Figures
References
-
- Alexander D, van Dyck PC. A vision of the future of newborn screening. Pediatrics. 2006;117:S350–54. - PubMed
-
- Am. Acad. Pediatr. Newborn Screen. Task Force. Newborn screening: a blueprint for the future executive summary: Newborn Screening Task Force report. Pediatrics. 2000;106:389–427. - PubMed
-
- Am. Coll. Med. Genet. Rep, Am Coll Med Genet. Rockville, MD: 2005. Newborn screening: toward a uniform screening panel and system.
-
- Am. Coll. Obstet. Gynecol. Comm. Genet. Committee opinion no. 481: newborn screening. Obstet Gynecol. 2011;117:762–65. - PubMed
-
-
Bearder et al. v. State of Minnesota. 2010. Minn. Court of Appeals A10-101 (Aug. 24)
-
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
